Home > News > Pro-Pharmaceuticals' Abstract Published
June 5th, 2006
Pro-Pharmaceuticals' Abstract Published
Abstract:
Pro-Pharmaceuticals, Inc. (Amex: PRW), a developer of novel nanotechnology carbohydrate therapeutic compounds, today announced that its abstract, "A Bio-distribution Study of DAVANAT(R) " was published in The American Society of Cancer Oncology's (ASCO) 2006 Annual Meeting Proceedings. The ASCO Annual Meeting is being held in Atlanta, Georgia, June 2-6.
Source:
businesswire
Bookmark:
Nanomedicine
Nano-needles for cells May 25th, 2013
UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery May 22nd, 2013
Single-Cell Transfection Tool Enables Added Control for Biological Studies: McCormick researchers develop method of delivering molecules into targeted cells May 22nd, 2013
How Gold Nanoparticles Can Help Fight Ovarian Cancer May 21st, 2013
Announcements
Nano-needles for cells May 25th, 2013
How do cold ions slide May 24th, 2013
Gold nanocrystal vibration captured on billion-frames-per-second film May 23rd, 2013
Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home: Glowing Plant seeks funds via crowdfunding and raises almost $400,000 May 23rd, 2013